Hisamitsu Pharmaceutical Co Inc banner

Hisamitsu Pharmaceutical Co Inc
TSE:4530

Watchlist Manager
Hisamitsu Pharmaceutical Co Inc Logo
Hisamitsu Pharmaceutical Co Inc
TSE:4530
Watchlist
Price: 6 040 JPY
Market Cap: ¥454B

Wall St Price Targets

Price Targets Summary
Hisamitsu Pharmaceutical Co Inc

There are no price targets for Hisamitsu Pharmaceutical Co Inc.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Hisamitsu Pharmaceutical Co Inc Competitors:
Price Targets
INMB
INmune Bio Inc
485% Upside
JEF
Jefferies Financial Group Inc
-2% Downside

Revenue
Forecast

1% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
1% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is 4%.

Gross Profit
Forecast

0% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
0% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Hisamitsu Pharmaceutical Co Inc

Operating Income
Forecast

-3% / Year
Past Growth
2% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-3% / Year
Past Growth
2% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been -3%. The projected CAGR for the next 14 years is 2%.

Pre-Tax Income
Forecast

-2% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-2% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Hisamitsu Pharmaceutical Co Inc

Net Income
Forecast

0% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
8%
Average Beat
0% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
8%
Average Beat

Over the last 14 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 3 years is 3%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Hisamitsu Pharmaceutical Co Inc's stock price target?
Not Available

Hisamitsu Pharmaceutical Co Inc does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Hisamitsu Pharmaceutical Co Inc?
Projected CAGR
4%

Over the last 14 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is 4%.

What is the Operating Income forecast for Hisamitsu Pharmaceutical Co Inc?
Projected CAGR
2%

Over the last 14 years, the compound annual growth rate for Operating Income has been -3%. The projected CAGR for the next 14 years is 2%.

What is the Net Income forecast for Hisamitsu Pharmaceutical Co Inc?
Projected CAGR
3%

Over the last 14 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 3 years is 3%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett